Profund Advisors’s Nuvation Bio NUVB Stock Holding History
Bought
Maintained
Sold
Other funds holding NUVB
Profund Advisors's NUVB Position: Q3 2026 in Review
Profund Advisors increased its Nuvation Bio (NUVB) stake by 298% in Q3 2026, buying an estimated $1.13M and bringing the position to 240,483 shares worth $1.35M. The position accounts for 0.04% of the portfolio, ranked #294.
Profund Advisors first reported a position in NUVB in Q4 2021 and has held it in 15 quarters since. 55 funds tracked by Wall St. Rank hold NUVB as of Q3 2026.
- Profund Advisors held 240,483 shares of Nuvation Bio worth $1.35M as of Q3 2026.
- Profund Advisors bought 179,994 Nuvation Bio shares in Q3 2026, an estimated $1.13M.
- Nuvation Bio made up 0.04% of Profund Advisors's portfolio in Q3 2026, its #294 holding.
- Profund Advisors first reported a position in Nuvation Bio in Q4 2021 and has held it in 15 quarters since.
- 55 funds tracked by Wall St. Rank held Nuvation Bio as of Q3 2026.
Based on Profund Advisors's 13F filing for Q3 2026, filed 29 Oct 2026.